Brammer Bio Holding Company, LLC, commonly referred to as Brammer Bio, is a leading player in the biopharmaceutical industry, headquartered in the United States. Founded in 2018, the company has rapidly established itself as a key provider of viral vector manufacturing services, catering to the growing demand for advanced therapies in gene and cell therapy sectors. With operational facilities strategically located across the US, Brammer Bio offers a unique suite of services that includes process development, clinical manufacturing, and commercial production of viral vectors. Their commitment to quality and innovation has positioned them as a trusted partner for biotech companies, enabling the successful delivery of life-changing therapies. Notable achievements include significant collaborations with major pharmaceutical firms, underscoring their market leadership and expertise in the rapidly evolving landscape of biomanufacturing.
We don't have data for Brammer Bio Holding Company, LLC, but we can show you information about their parent organization instead.
View parent company